The approval is based on a pair of multicenter, placebo-controlled 12-week studies that showed significantly more patients taking Eohilia achieved histologic remission vs
Address correspondence to: Wolfram Ruf or Thati Madhusudhan, Center for Thrombosis and Hemostasis (CTH), Medical Centre of the Johannes Gutenberg University, Langenbeckstrasse 1, 55131 Mainz, Germany
Risks and Side Effects Emerging Concerns in India 1
1eh and Supplementary Fig
Step 3: The Injection A small intramuscular injection is administered
Key questions to discuss include: Whether you meet NHS criteria for GLP-1 prescription (type 2 diabetes or obesity with complications) The evidenceor lack thereoffor GLP-1 use specifically in Hashimoto's management Potential interactions between GLP-1 medications and thyroid hormone replacement How GLP-1 therapy might affect your thyroid function monitoring schedule Alternative evidence-based approaches to managing metabolic symptoms in Hashimoto's The costs and practicalities of private prescription if NHS funding is not available Contraception requirements if you are of childbearing potential (GLP-1 medications should be avoided in pregnancy and breastfeeding) Your GP may recommend optimising your current thyroid management first , ensuring your levothyroxine dose is appropriate and that you are not over- or under-replaced
